Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
By Patrick Wingrove (Reuters) – Eli Lilly on Friday said its popular weight-loss drug Zepbound helped resolve moderate to severe…
2024
Fisker heads toward liquidation as creditors fight over assets
By Dietrich Knauth NEW YORK (Reuters) – Electric vehicle startup Fisker is headed towards a liquidation, attorneys said in U.S….
U.S. jet fuel output rises to pre-COVID levels as demand soars
By Shariq Khan and Seher Dareen NEW YORK (Reuters) – U.S. refiners pumped out jet fuel last week at the…
TikTok says US ban is inevitable without a court order blocking law
By David Shepardson WASHINGTON (Reuters) – TikTok and Chinese parent ByteDance on Thursday urged a U.S. court to strike down…
Anthropic launches newest AI model, three months after its last
By Jeffrey Dastin (Reuters) – Anthropic, a startup backed by Google and Amazon.com, on Thursday released an updated artificial intelligence…
Oracle to invest over $1 billion on AI, cloud computing in Spain
(Reuters) – Oracle on Thursday said it will invest more than $1 billion over the next 10 years in artificial…
Nestle, Coke take cautious approach to catering to Ozempic users
By Jessica DiNapoli NEW YORK (Reuters) -Nestle’s new food brand for people taking weight-loss drugs like Wegovy will note that…
Huge tech ETF set to buy $10 billion in Nvidia shares
By Suzanne McGee and Lisa Pauline Mattackal (Reuters) – One of the world’s largest technology funds is set to ramp…
Chile lithium projects garner interest from over 50 companies
By Fabian Cambero and Daina Beth Solomon SANTIAGO (Reuters) – More than 50 companies have expressed interest in developing lithium…
Apple suspends work on next high-end headset, to focus on cheaper model, the Information reports
(Reuters) – Apple has suspended work on its next high-end Vision headset, the Information reported on Tuesday, citing an employee…